[go: up one dir, main page]

WO2006037050A3 - Methods for treating congestive heart failure - Google Patents

Methods for treating congestive heart failure Download PDF

Info

Publication number
WO2006037050A3
WO2006037050A3 PCT/US2005/034846 US2005034846W WO2006037050A3 WO 2006037050 A3 WO2006037050 A3 WO 2006037050A3 US 2005034846 W US2005034846 W US 2005034846W WO 2006037050 A3 WO2006037050 A3 WO 2006037050A3
Authority
WO
WIPO (PCT)
Prior art keywords
heart failure
congestive heart
methods
treating congestive
treating
Prior art date
Application number
PCT/US2005/034846
Other languages
French (fr)
Other versions
WO2006037050A2 (en
Inventor
Daniela Salvemini
Yingjie Chen
Original Assignee
Metaphore Pharmaceuticals Inc
Univ Minnesota
Daniela Salvemini
Yingjie Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metaphore Pharmaceuticals Inc, Univ Minnesota, Daniela Salvemini, Yingjie Chen filed Critical Metaphore Pharmaceuticals Inc
Publication of WO2006037050A2 publication Critical patent/WO2006037050A2/en
Publication of WO2006037050A3 publication Critical patent/WO2006037050A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

What is provided is a method for treating congestive heart failure by administering to a subject in need thereof a therapeutically effective amount of a superoxide dismutase mimetic or a peroxynitrite decomposition catalyst.
PCT/US2005/034846 2004-09-24 2005-09-26 Methods for treating congestive heart failure WO2006037050A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61303904P 2004-09-24 2004-09-24
US60/613,039 2004-09-24

Publications (2)

Publication Number Publication Date
WO2006037050A2 WO2006037050A2 (en) 2006-04-06
WO2006037050A3 true WO2006037050A3 (en) 2006-06-01

Family

ID=36119572

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/034846 WO2006037050A2 (en) 2004-09-24 2005-09-26 Methods for treating congestive heart failure

Country Status (1)

Country Link
WO (1) WO2006037050A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2192899B1 (en) * 2007-08-28 2014-10-01 Technion Research and Development Foundation, Ltd. Transition metal complexes of corroles for preventing cardiovascular diseases or disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976498A (en) * 1995-08-17 1999-11-02 Neumann; William L. Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
US6455542B1 (en) * 1998-01-22 2002-09-24 Oxon Medica Inc. Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
US6544975B1 (en) * 1999-01-25 2003-04-08 National Jewish Medical And Research Center Substituted porphyrins

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976498A (en) * 1995-08-17 1999-11-02 Neumann; William L. Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
US6455542B1 (en) * 1998-01-22 2002-09-24 Oxon Medica Inc. Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
US6544975B1 (en) * 1999-01-25 2003-04-08 National Jewish Medical And Research Center Substituted porphyrins

Also Published As

Publication number Publication date
WO2006037050A2 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
WO2008051805A3 (en) Triazolo-pyridazine protein kinase modulators
PL1928499T3 (en) Use of a dpp-iv inhibitor to reduce hypoglycemic events
WO2009111239A3 (en) Pyrrolidine derivatives
WO2006127287A3 (en) Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
WO2008054585A3 (en) Use of pegylated il-10 to treat cancer
WO2006078463A3 (en) Method for treating cardiovascular disease
WO2007136759A3 (en) Method for the treatment and prevention of ocular disorders
WO2008136394A1 (en) Method for production of lactam compound, and intermediate for the production method
WO2008051808A3 (en) Bicyclic triazoles as protein kinase modulators
WO2011049344A3 (en) Method of preparing sitagliptin and intermediates used therein
WO2007015017A3 (en) Novel polyquinoline derivatives and the therapeutic use thereof
WO2008063932A3 (en) Method for treating age-related macular degeneration
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
WO2007018808A3 (en) Methods and intermediates for the synthesis of porphyrins
WO2008039941A3 (en) Scgb3a2 as a growth factor and anti-apoptotic agent
WO2008002614A3 (en) Pseudoazulenyl nitrones
WO2006118973A3 (en) Methods of using heterobyclic compounds for treatment of rectal cancer
WO2011001111A3 (en) Use of jasmonic acid to treat oily skin
WO2006037050A3 (en) Methods for treating congestive heart failure
WO2010039920A3 (en) Boldine compounds for promoting bone growth
WO2010025135A3 (en) Trimeprazine and ethopropazine derivatives for promoting bone growth
WO2009029836A3 (en) Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes
WO2007149305A3 (en) Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (sibx)
WO2005117913A3 (en) Ozonized pharmaceutical composition and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase